The role of bicarbonate in platelet additive solution for apheresis platelet concentrates stored with low residual plasma

Transfusion

Volumn 53, Issue 3, 2013, Pages 591-599

  Radwanski, Katherine ^a   Min, Kyungyoon ^a  

^a Fenwal Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; BUFFER; PHARMACEUTICAL VEHICLES AND ADDITIVES; PLATELET ADDITIVE SOLUTION; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG;

APHERESIS; ARTICLE; CONTROLLED STUDY; DRUG STORAGE; IN VITRO STUDY; METABOLISM; PH; PLASMA; THROMBOCYTE FUNCTION; THROMBOCYTE PRESERVATION;

BICARBONATES; BLOOD PLATELETS; BLOOD PRESERVATION; CELL SHAPE; GLUCOSE; HUMANS; HYDROGEN-ION CONCENTRATION; OSMOLAR CONCENTRATION; PLASMA; PLATELETPHERESIS; PRESERVATIVES, PHARMACEUTICAL; SOLUTIONS; TEMPERATURE;

EID: 84874946357     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03745.x     Document Type: Article

References (44)

1. Rock G, Swenson SD, Adams GA,. Platelet storage in a plasma-free medium. Transfusion 1985; 25: 551-6.
2. Adams GA,. In vivo and in vitro platelet function testing. Plasma Ther Transfus Technol 1982; 3: 265-72.
3. Rock G, Labow RS, Adams GA,. Storage of human platelet concentrates for transfusion. Prog Clin Biol Res 1988; 283: 673-704.
4. Adams G, Swenson S, Rock G,. Survival and recovery of human platelets stored for five days in a non-plasma medium. Blood 1986; 67: 672-5.
5. Holme S, Heaton WA, Courtright M,. Improved in vivo and in vitro viability of platelet concentrates stored for seven days in a platelet additive solution. Br J Haematol 1987; 66: 233-8.
6. Shimizu T, Shibata K, Kora S,. First autoclave-sterilized platelet-additive solution containing glucose with a physiological pH for the preparation of plasma-poor platelet concentrates. Vox Sang 1992; 62: 87-93.
7. Gulliksson H, Sallander S, Pedajas I, Christenson M, Wiechel B,. Storage of platelets in additive solutions: a new method for storage using sodium chloride solution. Transfusion 1992; 32: 435-40.
8. Gulliksson H,. Storage of platelets in additive solutions: the effect of citrate and acetate in in vitro studies. Transfusion 1993; 33: 301-3.
9. Gulliksson H, Eriksson L, Högman CF, Payrat JM,. Buffy-coat-derived platelet concentrates prepared from half-strength citrate CPD and CPD whole-blood units: comparison between three additive solutions: in vitro studies. Vox Sang 1995; 68: 152-9.
10. van Rhenen DJ, Vermeij H, Kappers-Klunne M, Payrat JM,. Evaluation of a new citrate-acetate-NaCl platelet additive solution for the storage of white cell-reduced platelet concentrates obtained from half-strength CPD pooled buffy coats. Transfusion 1995; 35: 50-3.
11. Bertolini F, Murphy S, Rebulla P, Sirchia G,. Role of acetate during platelet storage in a synthetic medium. Transfusion 1992; 32: 152-6.
12. Shimizu T, Murphy S,. Roles of acetate and phosphate in the successful storage of platelet concentrates prepared with an acetate-containing additive solution. Transfusion 1993; 33: 304-10.
13. Gulliksson H, Larsson S, Kumlien G, Shanwell A,. Storage of platelets in additive solutions: effects of phosphate. Vox Sang 2000; 78: 176-84.
14. Gulliksson H, Larsson S, Shanwell A, Pedajas I, Joie M, Flament J,. A system for the supply of platelets suspended in a storage medium including buffy-coat-derived platelet concentrates in combination with "split" apheresis platelets. Transfus Sci 1997; 18: 33-40.
15. Gulliksson H, AuBuchon JP, Vesterinen M, Sandgren P, Larsson S, Pickard CA, Herschel I, Roger J, Tracy JE, Langweiler M,; Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesium. Vox Sang 2002; 82: 131-6.
16. Gulliksson H, AuBuchon JP, Cardigan R, Van Der Meer PF, Murphy S, Prowse C, Richter E, Ringwald J, Smacchia C, Slichter S, de Wildt-Eggen J,. Storage of platelets in additive solutions: a multicentre study of the in vitro effects of potassium and magnesium. Vox Sang 2003; 85: 199-205.
17. Diedrich B, Sandgren P, Jansson B, Gulliksson H, Svensson L, Shanwell A,. In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution. Vox Sang 2008; 94: 96-102.
18. De Wildt-Eggen J, Nauta S, Schrijver JG, Van Marwijk Kooy M, Bins M, Van Prooijen HC,. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study. Transfusion 2000; 40: 398-403.
19. Kerkhoffs JL, Eikenboom JC, Schipperus MS, van Wordragen-Vlaswinkel RJ, Brand R, Harvey MS, de Vries RR, Barge R, van Rhenen DJ, Brand A,. A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma. Blood 2006; 108: 3210-5.
20. Janetzko K, Cazenave JP, Klüter H, Kientz D, Michel M, Beris P, Lioure B, Hastka J, Marblie S, Mayaudon V, Lin L, Lin JS, Conlan MG, Flament J,. Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set. Transfusion 2005; 45: 1443-52.
21. Johnson L, Winter KM, Hartkopf-Theis T, Reid S, Kwok M, Marks DC,. Evaluation of the automated collection and extended storage of apheresis platelets in additive solution. Transfusion 2011; 52: 503-9.
22. Vassallo RR, Adamson JW, Gottschall JL, Snyder EL, Lee W, Houghton J, Elfath MD,. In vitro and in vivo evaluation of apheresis platelets stored for 5 days in 65% platelet additive solution/35% plasma. Transfusion 2010; 50: 2376-85.
23. Radwanski K, Wagner SJ, Skripchenko A, Min K,. In vitro variables of apheresis platelets are stably maintained for 7 days with 5% residual plasma in a glucose and bicarbonate salt solution, PAS-5. Transfusion 2012; 52: 188-94.
24. Wagner SJ, Skripchenko A, Myrup A, Thompson-Montgomery D, Awatefe H, Moroff G,. Calcium is a key constituent for maintaining the in vitro properties of platelets suspended in the bicarbonate-containing additive solution M-sol with low plasma levels. Transfusion 2010; 50: 1028-35.
25. Kunicki TJ, Tuccelli M, Becker GA, Aster RH,. A study of variables affecting the quality of platelets stored at "room temperature." Transfusion 1975; 15: 414-21.
26. Holme S, Moroff G, Murphy S,. A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Transfusion 1998; 38: 31-40.
27. Hagberg IA, Akkøk ÇA, Lyberg T, Kjeldsen-Kragh J,. Apheresis-induced platelet activation: comparison of three types of cell separators. Transfusion 2000; 40: 182-92.
28. Dekkers DW, De Cuyper IM, Van Der Meer PF, Verhoeven AJ, De Korte D,. Influence of pH on stored human platelets. Transfusion 2007; 47: 1889-95.
29. de Wildt-Eggen J, Schrijver JG, Bouter-Valk HJ, Fijnheer R, Bins M, van Prooijen HC,. Improvement of platelet storage conditions by using new polyolefin containers. Transfusion 1997; 37: 476-81.
30. Van Der Meer P, Pietersz R, Reesink H,. Leucoreduced platelet concentrates in additive solution: an evaluation of filters and storage containers. Vox Sang 2001; 81: 102-7.
31. Cardigan R, Sutherland J, Garwood M, Bashir S, Turner C, Smith K, Hancock V, Wiltshire M, Pergande C, Williamson LM,. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags. Vox Sang 2008; 94: 103-12.
32. Van Der Meer PF, Gulliksson H, AuBuchon JP, Prowse C, Richter E, De Wildt-Eggen J,; Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Interruption of agitation of platelet concentrates: effects on in vitro parameters. Vox Sang 2005; 88: 227-34.
33. Hunter S, Nixon J, Murphy S,. The effect of the interruption of agitation on platelet quality during storage for transfusion. Transfusion 2001; 41: 809-14.
34. Dumont LJ, Gulliksson H, Van Der Meer PF, Murphy S, Nixon JG, De Wildt-Eggen J, Vandenbroeke T, Aubuchon JP,. Interruption of agitation of platelet concentrates: a multicenter in vitro study by the BEST Collaborative on the effects of shipping platelets. Transfusion 2007; 47: 1666-73.
35. Wagner SJ, Vassallo R, Skripchenko A, Einarson M, Seetharaman S, Moroff G,. The influence of simulated shipping conditions (24- or 30-hr interruption of agitation) on the in vitro properties of apheresis platelets during 7-day storage. Transfusion 2008; 48: 1072-80.
36. Picker SM, Speer R, Gathof BS,. Functional characteristics of buffy-coat PLTs photochemically treated with amotosalen-HCl for pathogen inactivation. Transfusion 2004; 44: 320-9.
37. Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP,. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004; 44: 877-85.
38. Picker SM, Schneider V, Oustianskaia L, Gathof BS,. Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies. Transfusion 2009; 49: 2311-8.
39. Bode AP, Miller DT,. Metabolic status of platelet concentrates during extended storage: improvement with pharmacological inhibitors and reduced surface-to-volume ratio. Vox Sang 1989; 57: 19-24.
40. Bode AP, Holme S, Heaton WA, Swanson MS,. Extended storage of platelets in an artificial medium with the platelet activation inhibitors prostaglandin E1 and theophylline1. Vox Sang 1991; 60: 105-12.
41. Baker JM, Candy DJ, Hawker RJ,. Influences of pH on human platelet metabolism. Platelets 2001; 12: 333-42.
42. Dumont LJ, AuBuchon JP, Gulliksson H, Slichter SJ, Elfath MD, Holme S, Murphy JR, Rose LE, Popovsky MA, Murphy S,. In vitro pH effects on in vivo recovery and survival of platelets: an analysis by the BEST Collaborative. Transfusion 2006; 46: 1300-5.
43. European Union. COMMISSION DIRECTIVE 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components. Off J Eur Union. 2004:L91/25-39.
44. European Union. COMMISSION DIRECTIVE 2011/38/EU of 11 April 2011 amending Annex V to Directive 2004/33/EC with regards to maximum pH values for platelets concentrates at the end of the shelf life. Off J Eur Union. 2011:L97/28-29.